The Intraocular lens is a lens implanted in the eye as part of a cure for cataracts or myopia. The most common form of the IOL is the pseudophakic IOL. These are implemented in the case of Cataract surgery after the herbal lens of the cloudy eye (cataract) was eliminated. The pseudophakic IOL provides the same moderate focus function as the Natural crystalline.
Increase in geriatric population exposed to ocular conditions, growing prevalence of cataract, and increase in initiatives taken by government to eliminate avoidable blindness are the major factors driving the market. However, unfavorable reimbursement policies and complications such as refractive errors are expected to be a major constraint.
The Asia Pacific Intraocular Lens market has geographically segmented into China, India, Japan, South Korea, and Australia. Asia Pacific has significant growth owing to government initiatives and awareness programs to eliminate avoidable blindness.
Major companies in the market are Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, and Oculentis GmBH.
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
